Clinical Trial: Open Label, Safety and Efficacy Study of QRX003 Lotion in Subjects With Netherton Syndrome

Study Status: RECRUITING
Recruit Status: RECRUITING
Study Type: INTERVENTIONAL




Official Title: A Multicenter, Open Label Study of QRX003 Lotion in Subjects With Netherton Syndrome

Brief Summary: To assess the safety, tolerability, and efficacy of QRX003 lotion (4%) when added to standard of care treatment regimen, including systemic therapy in subjects with Netherton syndrome